FindTrial
Sign In

MRI study of peripheral nerve injury in diabetes mellitus

MRI study of peripheral nerve injury in diabetes mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090734
Enrollment
Unknown
Registered
2024-10-12
Start date
2024-10-20
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

Gold Standard:Nerve conduction tests are now the ‘gold standard’ for diagnosing DPN.
Index test:Equipment: 3.0 T MR Imaging biomarkers: Fractional Anisotraphy (FA), Apparent Diffusion Coefficient (ADC),Mean Diffusivity(MD)

Sponsors

Guiqian International Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with clinically diagnosed diabetes mellitus

Exclusion criteria

Exclusion criteria: Nerve damage due to other reasons such as trauma; pregnancy, history of leg or knee surgery, history of exposure to nerve agents, and general contraindications to cardiovascular, pulmonary, endocrine, metabolic, neurological, neuromuscular, or knee-related muscular disorders; and inability to co-operate with the completion of the MR examination or substandard image quality.

Design outcomes

Primary

MeasureTime frame
Fractional Anisotraphy(FA);—

Secondary

MeasureTime frame
Apparent Diffusion Coefficient(ADC);Mean Diffusivity(MD);—

Countries

China

Contacts

Public ContactWeiling Wang

Guiqian International Hospital

xiaoyezhuabc@hotmail.com+86 186 8501 3311

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026